GlassScriptPhysician profile
Jamie R Smith
NPI 1952536138
$2,229.05
in general payments reported to CMS, 2019-2025
26 companies · $952 in 2025
The $952 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $105 · 2022: $363 · 2023: $458 · 2024: $351 · 2025: $952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498 · Education: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,498.02 |
| Education | $263.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $362.13 | 2023-2025 | Veozah |
| Abbvie INC. | $239.00 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $211.73 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $209.08 | 2021-2025 | |
| Exeltis, USA INC. | $157.68 | 2022-2025 | Slynd |
| Organon LLC | $132.30 | 2021-2025 | Nexplanon, Nuvaring |
| Millicent US INC | $117.48 | 2025 | Intrarosa, Femring |
| Sumitomo Pharma America, INC. | $91.03 | 2024-2025 | Myfembree, Gemtesa |
| Baxter Healthcare | $87.84 | 2024-2025 | Perclot, Tisseel |
| Sage Therapeutics, LLC | $86.95 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $82.05 | 2021-2025 | Aptima, Thinprep 2000 Processor, I -View Contrast Enhanced Digital Mammography |
| Pfizer INC. | $78.13 | 2023-2025 | |
| Coopersurgical, INC. | $58.12 | 2023-2025 | Paragard T 380a, Summit Doppler |
| Novo Nordisk INC | $40.14 | 2023-2024 | Wegovy |
| Myovant Sciences INC. | $32.37 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $31.99 | 2025 | The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $29.16 | 2022 | |
| Becton, Dickinson and Company | $29.04 | 2024 | Bd Onclarity |
| Boston Scientific Corporation | $23.13 | 2022 | |
| Merck Sharp & Dohme LLC | $23.02 | 2021 | |
| Lilly USA, LLC | $22.86 | 2025 | Mounjaro, Zepbound |
| Gynesonics, INC. | $19.82 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Medicem INC. | $18.48 | 2022 | |
| Coloplast Corp | $17.88 | 2022 | |
| Therapeuticsmd, INC. | $15.62 | 2022 | |
| Dysis Medical, INC. | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.